Literature DB >> 25966839

Immunizations in Pediatric and Adult Patients with Inflammatory Bowel Disease: A Practical Case-based Approach.

Millie D Long1, Ajay Gulati, David Wohl, Hans Herfarth.   

Abstract

As the treatment of inflammatory bowel disease (IBD) becomes more complex and increasingly relies on combinations of immunosuppression in patients with moderate to severe ulcerative colitis or Crohn's disease, the provider must be aware of recommendations for the appropriate use of vaccines-both inactivated and live. The timing and type of vaccination required may be altered based on the underlying medical treatment for the IBD. In some instances, titers may be required to assess for vaccine response. Vaccination recommendations have changed dramatically over the past 5 years with direct implications for the protection of the patients with IBD. There are several newly licensed vaccines and new recommendations by the U.S. Advisory Committee on Immunization Practices and Infectious Diseases Society of America defining degrees of immunosuppression and the use of certain live vaccines based on these levels. This review provides a case-based approach to vaccinating the pediatric and adult patients with IBD, with an emphasis on practicality. Case scenarios include children and adults with newly diagnosed and chronic IBD. Recommendations for vaccine management in these scenarios are provided, including special circumstances such as pregnancy and infant vaccinations when the mother is receiving immunosuppressive medication.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25966839     DOI: 10.1097/MIB.0000000000000395

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  10 in total

1.  Vaccination of Patients With Inflammatory Bowel Disease During the COVID-19 Pandemic.

Authors:  Sheena Crosby; Michael J Schuh; Freddy Caldera; Francis A Farraye
Journal:  Gastroenterol Hepatol (N Y)       Date:  2021-01

Review 2.  A Practical Guide to the Safety and Monitoring of New IBD Therapies.

Authors:  Benjamin Click; Miguel Regueiro
Journal:  Inflamm Bowel Dis       Date:  2019-04-11       Impact factor: 5.325

Review 3.  ACG Clinical Guideline: Preventive Care in Inflammatory Bowel Disease.

Authors:  Francis A Farraye; Gil Y Melmed; Gary R Lichtenstein; Sunanda V Kane
Journal:  Am J Gastroenterol       Date:  2017-01-10       Impact factor: 10.864

4.  Vaccinating Patients With Inflammatory Bowel Disease.

Authors:  Jason Reich; Sharmeel Wasan; Francis A Farraye
Journal:  Gastroenterol Hepatol (N Y)       Date:  2016-09

Review 5.  Preventative Care in the Patient with Inflammatory Bowel Disease: What Is New?

Authors:  Jason S Reich; Francis A Farraye; Sharmeel K Wasan
Journal:  Dig Dis Sci       Date:  2016-04-09       Impact factor: 3.199

Review 6.  Vaccines: Considerations for pediatric dermatology patients on immunosuppressive agents.

Authors:  Mumtaz A Munshi; Megan H Noe; Yvonne E Chiu; Jenna L Streicher
Journal:  Pediatr Dermatol       Date:  2021-06-01       Impact factor: 1.997

Review 7.  Health Maintenance in Inflammatory Bowel Disease.

Authors:  Fazia A Mir; Sunanda V Kane
Journal:  Curr Gastroenterol Rep       Date:  2018-04-17

Review 8.  A Review of Vaccinations in Adult Patients with Secondary Immunodeficiency.

Authors:  Elda Righi; Tolinda Gallo; Anna Maria Azzini; Fulvia Mazzaferri; Maddalena Cordioli; Mara Merighi; Evelina Tacconelli
Journal:  Infect Dis Ther       Date:  2021-03-09

Review 9.  Health Maintenance for Adult Patients with Inflammatory Bowel Disease.

Authors:  Jana G Hashash; Michael F Picco; Francis A Farraye
Journal:  Curr Treat Options Gastroenterol       Date:  2021-11-22

Review 10.  Vaccinations in Adult Patients with Inflammatory Bowel Diseases in the West.

Authors:  Bharati Kochar; Hans H Herfarth
Journal:  Inflamm Intest Dis       Date:  2018-07-12
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.